episalvan (Pending FDA Approval)

Brand and Other Names:Filsuvez, Oleogel-S10
  • Print

Dosing & Uses

Epidermolysis Bullosa

Topical agent pending FDA approval for cutaneous manifestations of epidermolysis bullosa

Next:

Pharmacology

Mechanism of Action

Wound healing gel containing extract from birch bark rich in betulin

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.